These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 26607904

  • 1. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL, Park JY, Kim EH, Jang HJ, Kwon M.
    Cancer Lett; 2016 Feb 01; 371(1):20-9. PubMed ID: 26607904
    [Abstract] [Full Text] [Related]

  • 2. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL, Kim EH, Jang HJ, Park JY, Shin D.
    Cancer Lett; 2016 Oct 10; 381(1):96-103. PubMed ID: 27477897
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
    Kim EH, Jang H, Shin D, Baek SH, Roh JL.
    Apoptosis; 2016 Nov 10; 21(11):1265-1278. PubMed ID: 27544755
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL, Kim EH, Jang H, Shin D.
    Redox Biol; 2017 Apr 10; 11():254-262. PubMed ID: 28012440
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species.
    Kang SU, Cho JH, Chang JW, Shin YS, Kim KI, Park JK, Yang SS, Lee JS, Moon E, Lee K, Kim CH.
    Cell Death Dis; 2014 Feb 13; 5(2):e1056. PubMed ID: 24525732
    [Abstract] [Full Text] [Related]

  • 9. Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway.
    Kim EH, Baek S, Shin D, Lee J, Roh JL.
    Oxid Med Cell Longev; 2017 Feb 13; 2017():5498908. PubMed ID: 29456786
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition.
    Kim EH, Jang H, Roh JL.
    Mol Cancer Ther; 2016 Nov 13; 15(11):2620-2629. PubMed ID: 27550943
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D, Kim EH, Lee J, Roh JL.
    Free Radic Biol Med; 2018 Dec 13; 129():454-462. PubMed ID: 30339884
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer.
    Roh JL, Kim EH, Park JY, Kim JW, Kwon M, Lee BH.
    Oncotarget; 2014 Oct 15; 5(19):9227-38. PubMed ID: 25193861
    [Abstract] [Full Text] [Related]

  • 16. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems.
    Shin D, Kim EH, Lee J, Roh JL.
    Redox Biol; 2017 Oct 15; 13():219-227. PubMed ID: 28582730
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin.
    Roh JL, Kim EH, Park JY, Kim JW.
    Mol Cancer Ther; 2015 Aug 15; 14(8):1907-15. PubMed ID: 26063766
    [Abstract] [Full Text] [Related]

  • 18. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
    Neveu MA, De Preter G, Joudiou N, Bol A, Brender JR, Saito K, Kishimoto S, Grégoire V, Jordan BF, Krishna MC, Feron O, Gallez B.
    Oncotarget; 2016 Dec 06; 7(49):81741-81749. PubMed ID: 28082726
    [Abstract] [Full Text] [Related]

  • 19. Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation.
    Kumar A, Kant S, Singh SM.
    Chem Biol Interact; 2012 Jul 30; 199(1):29-37. PubMed ID: 22705712
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.